Analysis of the prognostic factors in primary plasma cell leukemia in the era of novel agents  

作　　者：DENG Jingjing 邓晶晶(Beijing Chaoyang Hosp,Capital Med Univ,Beijing 100020)

机构地区：[1]Beijing Chaoyang Hosp,Capital Med Univ,Beijing 100020

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第4期229-229,共1页中国医学文摘(内科学分册英文版)

摘　　要：Objective To explore the prognostic factors of primary plasma cell leukemia(pPCL)in the era of novel agents.Methods The clinical data of 66 patients with pPCL treated at the Department of Haematology,Beijing Chao-Yang Hospital,Capital Medical University from 2011 to 2022 were retrospectively collected to analyze their prognostic factors.

关 键 词：LEUKEMIA CLINICAL MEDICAL 

分 类 号：R73[医药卫生—肿瘤]